Your browser doesn't support javascript.
loading
Protection against SARS-CoV-2 transmission by a parenteral prime-Intranasal boost vaccine strategy.
Christensen, Dennis; Polacek, Charlotta; Sheward, Daniel J; Hanke, Leo; Moliner-Morro, Ainhoa; McInerney, Gerald; Murrell, Ben; Hartmann, Katrine Top; Jensen, Henrik Elvang; Jungersen, Gregers; Illigen, Kristin; Isling, Louise Krag; Jensen, Rune Fledelius; Hansen, Julia Sid; Rosenkrands, Ida; Fernandez-Antunez, Carlota; Ramirez, Santseharay; Follmann, Frank; Bukh, Jens; Pedersen, Gabriel Kristian.
Afiliação
  • Christensen D; Center for Vaccine Research, Statens Serum Institut, Copenhagen, Denmark.
  • Polacek C; Virus Research & Development Laboratory, Department of Virology and Microbiological Special diagnostics, Statens Serum Institut, Copenhagen, Denmark.
  • Sheward DJ; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.
  • Hanke L; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.
  • Moliner-Morro A; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.
  • McInerney G; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.
  • Murrell B; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.
  • Hartmann KT; Department of Veterinary and Animal Sciences, University of Copenhagen, Copenhagen Denmark.
  • Jensen HE; Department of Veterinary and Animal Sciences, University of Copenhagen, Copenhagen Denmark.
  • Jungersen G; Center for Vaccine Research, Statens Serum Institut, Copenhagen, Denmark.
  • Illigen K; Center for Vaccine Research, Statens Serum Institut, Copenhagen, Denmark.
  • Isling LK; Center for Vaccine Research, Statens Serum Institut, Copenhagen, Denmark.
  • Jensen RF; Center for Vaccine Research, Statens Serum Institut, Copenhagen, Denmark.
  • Hansen JS; Center for Vaccine Research, Statens Serum Institut, Copenhagen, Denmark.
  • Rosenkrands I; Center for Vaccine Research, Statens Serum Institut, Copenhagen, Denmark.
  • Fernandez-Antunez C; Copenhagen Hepatitis C Program (CO-HEP), Department of Infectious Diseases, Copenhagen University Hospital, Hvidovre, and Department of Immunology and Microbiology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Ramirez S; Copenhagen Hepatitis C Program (CO-HEP), Department of Infectious Diseases, Copenhagen University Hospital, Hvidovre, and Department of Immunology and Microbiology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Follmann F; Center for Vaccine Research, Statens Serum Institut, Copenhagen, Denmark.
  • Bukh J; Copenhagen Hepatitis C Program (CO-HEP), Department of Infectious Diseases, Copenhagen University Hospital, Hvidovre, and Department of Immunology and Microbiology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Pedersen GK; Center for Vaccine Research, Statens Serum Institut, Copenhagen, Denmark. Electronic address: gakp@ssi.dk.
EBioMedicine ; 84: 104248, 2022 Oct.
Article em En | MEDLINE | ID: mdl-36088218
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article